nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—Hydrocortisone—ulcerative colitis	0.403	1	CrCtD
Levonorgestrel—PGR—Betamethasone—ulcerative colitis	0.0487	0.193	CbGbCtD
Levonorgestrel—SHBG—Hydrocortisone—ulcerative colitis	0.0437	0.174	CbGbCtD
Levonorgestrel—CYP19A1—Nicotine—ulcerative colitis	0.041	0.163	CbGbCtD
Levonorgestrel—PGR—Dexamethasone—ulcerative colitis	0.0283	0.112	CbGbCtD
Levonorgestrel—CYP19A1—Betamethasone—ulcerative colitis	0.0274	0.109	CbGbCtD
Levonorgestrel—Hydrocortisone—Budesonide—ulcerative colitis	0.0241	0.0948	CrCrCtD
Levonorgestrel—Danazol—Hydrocortisone—ulcerative colitis	0.0207	0.0813	CrCrCtD
Levonorgestrel—Norethindrone—Hydrocortisone—ulcerative colitis	0.018	0.0707	CrCrCtD
Levonorgestrel—Danazol—Prednisone—ulcerative colitis	0.0178	0.07	CrCrCtD
Levonorgestrel—CYP19A1—Dexamethasone—ulcerative colitis	0.0159	0.0633	CbGbCtD
Levonorgestrel—Progesterone—Hydrocortisone—ulcerative colitis	0.0151	0.0595	CrCrCtD
Levonorgestrel—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.0151	0.0595	CrCrCtD
Levonorgestrel—Methyltestosterone—Hydrocortisone—ulcerative colitis	0.0148	0.058	CrCrCtD
Levonorgestrel—Testosterone—Hydrocortisone—ulcerative colitis	0.0132	0.0517	CrCrCtD
Levonorgestrel—Progesterone—Prednisolone—ulcerative colitis	0.0127	0.05	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisone—ulcerative colitis	0.0127	0.05	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisolone—ulcerative colitis	0.0124	0.0488	CrCrCtD
Levonorgestrel—CYP3A4—Budesonide—ulcerative colitis	0.0119	0.0475	CbGbCtD
Levonorgestrel—Hydrocortisone—Methylprednisolone—ulcerative colitis	0.0117	0.0458	CrCrCtD
Levonorgestrel—Hydrocortisone—Dexamethasone—ulcerative colitis	0.0115	0.0451	CrCrCtD
Levonorgestrel—Hydrocortisone—Betamethasone—ulcerative colitis	0.0115	0.0451	CrCrCtD
Levonorgestrel—Hydrocortisone—Triamcinolone—ulcerative colitis	0.0112	0.044	CrCrCtD
Levonorgestrel—Testosterone—Prednisolone—ulcerative colitis	0.0111	0.0434	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisone—ulcerative colitis	0.0106	0.0418	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisolone—ulcerative colitis	0.0104	0.0408	CrCrCtD
Levonorgestrel—CYP3A4—Methylprednisolone—ulcerative colitis	0.00534	0.0212	CbGbCtD
Levonorgestrel—CYP3A4—Nicotine—ulcerative colitis	0.0052	0.0207	CbGbCtD
Levonorgestrel—CYP3A4—Cholecalciferol—ulcerative colitis	0.00466	0.0185	CbGbCtD
Levonorgestrel—CYP3A4—Triamcinolone—ulcerative colitis	0.00404	0.0161	CbGbCtD
Levonorgestrel—CYP3A4—Betamethasone—ulcerative colitis	0.00347	0.0138	CbGbCtD
Levonorgestrel—CYP3A4—Prednisolone—ulcerative colitis	0.00342	0.0136	CbGbCtD
Levonorgestrel—CYP3A4—Hydrocortisone—ulcerative colitis	0.00325	0.0129	CbGbCtD
Levonorgestrel—CYP3A4—Prednisone—ulcerative colitis	0.00323	0.0128	CbGbCtD
Levonorgestrel—CYP3A4—Dexamethasone—ulcerative colitis	0.00202	0.00802	CbGbCtD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—VCAM1—ulcerative colitis	0.00035	0.0217	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—NR5A2—ulcerative colitis	0.000345	0.0214	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptors—HNF4A—ulcerative colitis	0.000328	0.0204	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—COL18A1—ulcerative colitis	0.000311	0.0193	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—COL18A1—ulcerative colitis	0.000302	0.0187	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000273	0.0169	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00026	0.0161	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IL23A—ulcerative colitis	0.000258	0.016	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—HNF4A—ulcerative colitis	0.00025	0.0155	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—PARK7—ulcerative colitis	0.000241	0.0149	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—COL18A1—ulcerative colitis	0.000239	0.0148	CbGpPWpGaD
Levonorgestrel—PGR—Ovarian Infertility Genes—VDR—ulcerative colitis	0.000235	0.0145	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—MAML2—ulcerative colitis	0.000206	0.0128	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptors—VDR—ulcerative colitis	0.000205	0.0127	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000198	0.0123	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—TCF4—ulcerative colitis	0.000198	0.0122	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—HNF4A—ulcerative colitis	0.000193	0.0119	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—ulcerative colitis	0.000177	0.011	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000175	0.0108	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—ulcerative colitis	0.000168	0.0104	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000162	0.01	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—IL1B—ulcerative colitis	0.000162	0.01	CbGpPWpGaD
Levonorgestrel—Testosterone—SLC22A4—ulcerative colitis	0.00016	0.298	CrCbGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—ulcerative colitis	0.000159	0.00986	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—VDR—ulcerative colitis	0.000156	0.00966	CbGpPWpGaD
Levonorgestrel—CYP19A1—Ovarian Infertility Genes—VDR—ulcerative colitis	0.000154	0.00954	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000152	0.00944	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptors—PPARG—ulcerative colitis	0.000143	0.00884	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—ulcerative colitis	0.000137	0.00846	CbGpPWpGaD
Levonorgestrel—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000136	0.00845	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000133	0.00825	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000131	0.00811	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—ulcerative colitis	0.000129	0.008	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000123	0.00763	CbGpPWpGaD
Levonorgestrel—ESR1—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000121	0.00751	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—VDR—ulcerative colitis	0.00012	0.00744	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—TNF—ulcerative colitis	0.000117	0.00727	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear signaling by ERBB4—JAK2—ulcerative colitis	0.000117	0.00724	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000113	0.00698	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—PPARG—ulcerative colitis	0.000109	0.00673	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CHP1—ulcerative colitis	0.000108	0.00671	CbGpPWpGaD
Levonorgestrel—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000108	0.00669	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—HNF4A—ulcerative colitis	0.000105	0.00652	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000103	0.00636	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000101	0.00628	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000101	0.00625	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	9.92e-05	0.00615	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	9.49e-05	0.00588	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—DLD—ulcerative colitis	9.34e-05	0.00579	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	8.58e-05	0.00532	CbGpPWpGaD
Levonorgestrel—ESR1—Estrogen signaling pathway—NFKB1—ulcerative colitis	8.54e-05	0.00529	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—VDR—ulcerative colitis	8.5e-05	0.00527	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—ZFP90—ulcerative colitis	8.41e-05	0.00521	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—PPARG—ulcerative colitis	8.37e-05	0.00519	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—IL10—ulcerative colitis	8.27e-05	0.00513	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NR5A2—ulcerative colitis	8.02e-05	0.00497	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—JAK2—ulcerative colitis	7.66e-05	0.00475	CbGpPWpGaD
Levonorgestrel—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	7.46e-05	0.00463	CbGpPWpGaD
Levonorgestrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	7.45e-05	0.00462	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—CD4—ulcerative colitis	7.26e-05	0.0045	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL10—ulcerative colitis	7.16e-05	0.00444	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—ulcerative colitis	7.03e-05	0.00436	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.87e-05	0.00426	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear signaling by ERBB4—JAK2—ulcerative colitis	6.85e-05	0.00425	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	6.61e-05	0.0041	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—ulcerative colitis	6.55e-05	0.00406	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ZFP90—ulcerative colitis	6.41e-05	0.00397	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—ulcerative colitis	6.37e-05	0.00395	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NR5A2—ulcerative colitis	6.11e-05	0.00379	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP1—ulcerative colitis	6.09e-05	0.00378	CbGpPWpGaD
Levonorgestrel—Norethindrone—ALB—ulcerative colitis	6.07e-05	0.113	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ABCB1—ulcerative colitis	6.02e-05	0.112	CrCbGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	5.81e-05	0.0036	CbGpPWpGaD
Levonorgestrel—Norethindrone—ABCB1—ulcerative colitis	5.79e-05	0.108	CrCbGaD
Levonorgestrel—Methyltestosterone—ALB—ulcerative colitis	5.76e-05	0.107	CrCbGaD
Levonorgestrel—CYP19A1—Biological oxidations—PTGS1—ulcerative colitis	5.73e-05	0.00355	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ulcerative colitis	5.71e-05	0.00354	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	5.65e-05	0.0035	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—STAT3—ulcerative colitis	5.62e-05	0.00349	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—ulcerative colitis	5.43e-05	0.00337	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	5.3e-05	0.00328	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.94e-05	0.00306	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—ZFP90—ulcerative colitis	4.94e-05	0.00306	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	4.9e-05	0.00304	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL10—ulcerative colitis	4.9e-05	0.00304	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IFNG—ulcerative colitis	4.83e-05	0.00299	CbGpPWpGaD
Levonorgestrel—Rash—Budesonide—ulcerative colitis	4.71e-05	0.00064	CcSEcCtD
Levonorgestrel—ESR1—Generic Transcription Pathway—NR5A2—ulcerative colitis	4.71e-05	0.00292	CbGpPWpGaD
Levonorgestrel—Dermatitis—Budesonide—ulcerative colitis	4.71e-05	0.00064	CcSEcCtD
Levonorgestrel—Headache—Budesonide—ulcerative colitis	4.68e-05	0.000636	CcSEcCtD
Levonorgestrel—Hypertension—Prednisolone—ulcerative colitis	4.68e-05	0.000636	CcSEcCtD
Levonorgestrel—Loss of consciousness—Hydrocortisone—ulcerative colitis	4.66e-05	0.000633	CcSEcCtD
Levonorgestrel—Arrhythmia—Dexamethasone—ulcerative colitis	4.64e-05	0.000631	CcSEcCtD
Levonorgestrel—Arrhythmia—Betamethasone—ulcerative colitis	4.64e-05	0.000631	CcSEcCtD
Levonorgestrel—Alopecia—Dexamethasone—ulcerative colitis	4.59e-05	0.000624	CcSEcCtD
Levonorgestrel—Alopecia—Betamethasone—ulcerative colitis	4.59e-05	0.000624	CcSEcCtD
Levonorgestrel—Hypertension—Hydrocortisone—ulcerative colitis	4.57e-05	0.000621	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ulcerative colitis	4.57e-05	0.00283	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Azathioprine—ulcerative colitis	4.57e-05	0.00062	CcSEcCtD
Levonorgestrel—Discomfort—Prednisolone—ulcerative colitis	4.56e-05	0.00062	CcSEcCtD
Levonorgestrel—Angioedema—Triamcinolone—ulcerative colitis	4.56e-05	0.000619	CcSEcCtD
Levonorgestrel—Haemoglobin—Prednisone—ulcerative colitis	4.55e-05	0.000618	CcSEcCtD
Levonorgestrel—Angioedema—Methylprednisolone—ulcerative colitis	4.55e-05	0.000618	CcSEcCtD
Levonorgestrel—Haemorrhage—Prednisone—ulcerative colitis	4.53e-05	0.000615	CcSEcCtD
Levonorgestrel—Erythema—Betamethasone—ulcerative colitis	4.53e-05	0.000615	CcSEcCtD
Levonorgestrel—Erythema—Dexamethasone—ulcerative colitis	4.53e-05	0.000615	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—PTGS1—ulcerative colitis	4.52e-05	0.0028	CbGpPWpGaD
Levonorgestrel—Myalgia—Hydrocortisone—ulcerative colitis	4.51e-05	0.000613	CcSEcCtD
Levonorgestrel—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	4.5e-05	0.00279	CbGpPWpGaD
Levonorgestrel—Anxiety—Hydrocortisone—ulcerative colitis	4.49e-05	0.000611	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CXCL8—ulcerative colitis	4.49e-05	0.00278	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—HNF4A—ulcerative colitis	4.48e-05	0.00278	CbGpPWpGaD
Levonorgestrel—Vertigo—Triamcinolone—ulcerative colitis	4.48e-05	0.000609	CcSEcCtD
Levonorgestrel—Hypersensitivity—Mesalazine—ulcerative colitis	4.48e-05	0.000609	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	4.48e-05	0.000609	CcSEcCtD
Levonorgestrel—Syncope—Triamcinolone—ulcerative colitis	4.47e-05	0.000608	CcSEcCtD
Levonorgestrel—Vertigo—Methylprednisolone—ulcerative colitis	4.47e-05	0.000608	CcSEcCtD
Levonorgestrel—Syncope—Methylprednisolone—ulcerative colitis	4.46e-05	0.000606	CcSEcCtD
Levonorgestrel—Discomfort—Hydrocortisone—ulcerative colitis	4.46e-05	0.000605	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—RELA—ulcerative colitis	4.45e-05	0.00276	CbGpPWpGaD
Levonorgestrel—Connective tissue disorder—Prednisone—ulcerative colitis	4.45e-05	0.000605	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.44e-05	0.00275	CbGpPWpGaD
Levonorgestrel—Nausea—Budesonide—ulcerative colitis	4.44e-05	0.000603	CcSEcCtD
Levonorgestrel—Oedema—Prednisolone—ulcerative colitis	4.43e-05	0.000601	CcSEcCtD
Levonorgestrel—Dizziness—Azathioprine—ulcerative colitis	4.41e-05	0.0006	CcSEcCtD
Levonorgestrel—Loss of consciousness—Triamcinolone—ulcerative colitis	4.38e-05	0.000596	CcSEcCtD
Levonorgestrel—Loss of consciousness—Methylprednisolone—ulcerative colitis	4.37e-05	0.000594	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—MAML2—ulcerative colitis	4.37e-05	0.00271	CbGpPWpGaD
Levonorgestrel—Asthenia—Mesalazine—ulcerative colitis	4.36e-05	0.000593	CcSEcCtD
Levonorgestrel—Shock—Prednisolone—ulcerative colitis	4.35e-05	0.000592	CcSEcCtD
Levonorgestrel—Cough—Triamcinolone—ulcerative colitis	4.35e-05	0.000591	CcSEcCtD
Levonorgestrel—SRD5A1—liver—ulcerative colitis	4.34e-05	0.137	CbGeAlD
Levonorgestrel—Oedema—Hydrocortisone—ulcerative colitis	4.32e-05	0.000587	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—IFNG—ulcerative colitis	4.31e-05	0.00267	CbGpPWpGaD
Levonorgestrel—Hypertension—Triamcinolone—ulcerative colitis	4.31e-05	0.000585	CcSEcCtD
Levonorgestrel—Pruritus—Mesalazine—ulcerative colitis	4.3e-05	0.000584	CcSEcCtD
Levonorgestrel—Hypertension—Methylprednisolone—ulcerative colitis	4.3e-05	0.000584	CcSEcCtD
Levonorgestrel—Infection—Hydrocortisone—ulcerative colitis	4.29e-05	0.000584	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	4.29e-05	0.00266	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	4.29e-05	0.00266	CbGpPWpGaD
Levonorgestrel—Hyperhidrosis—Prednisolone—ulcerative colitis	4.28e-05	0.000581	CcSEcCtD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	4.28e-05	0.00265	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	4.27e-05	0.00265	CbGpPWpGaD
Levonorgestrel—Shock—Hydrocortisone—ulcerative colitis	4.25e-05	0.000578	CcSEcCtD
Levonorgestrel—Myalgia—Triamcinolone—ulcerative colitis	4.25e-05	0.000577	CcSEcCtD
Levonorgestrel—Vomiting—Azathioprine—ulcerative colitis	4.24e-05	0.000577	CcSEcCtD
Levonorgestrel—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.24e-05	0.000576	CcSEcCtD
Levonorgestrel—Myalgia—Methylprednisolone—ulcerative colitis	4.24e-05	0.000576	CcSEcCtD
Levonorgestrel—Eye disorder—Prednisone—ulcerative colitis	4.23e-05	0.000575	CcSEcCtD
Levonorgestrel—Anxiety—Methylprednisolone—ulcerative colitis	4.22e-05	0.000574	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IFNG—ulcerative colitis	4.21e-05	0.00261	CbGpPWpGaD
Levonorgestrel—Rash—Azathioprine—ulcerative colitis	4.21e-05	0.000572	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.21e-05	0.000572	CcSEcCtD
Levonorgestrel—Dermatitis—Azathioprine—ulcerative colitis	4.2e-05	0.000571	CcSEcCtD
Levonorgestrel—Skin disorder—Hydrocortisone—ulcerative colitis	4.2e-05	0.000571	CcSEcCtD
Levonorgestrel—Discomfort—Triamcinolone—ulcerative colitis	4.19e-05	0.00057	CcSEcCtD
Levonorgestrel—Discomfort—Methylprednisolone—ulcerative colitis	4.19e-05	0.000569	CcSEcCtD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	4.18e-05	0.00259	CbGpPWpGaD
Levonorgestrel—Headache—Azathioprine—ulcerative colitis	4.18e-05	0.000568	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.18e-05	0.000568	CcSEcCtD
Levonorgestrel—Diarrhoea—Mesalazine—ulcerative colitis	4.16e-05	0.000565	CcSEcCtD
Levonorgestrel—Hydrocortisone—ABCB1—ulcerative colitis	4.14e-05	0.0771	CrCbGaD
Levonorgestrel—Angioedema—Dexamethasone—ulcerative colitis	4.13e-05	0.000562	CcSEcCtD
Levonorgestrel—Angioedema—Betamethasone—ulcerative colitis	4.13e-05	0.000562	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ulcerative colitis	4.13e-05	0.00256	CbGpPWpGaD
Levonorgestrel—Anorexia—Hydrocortisone—ulcerative colitis	4.12e-05	0.00056	CcSEcCtD
Levonorgestrel—Immune system disorder—Prednisone—ulcerative colitis	4.09e-05	0.000556	CcSEcCtD
Levonorgestrel—Oedema—Triamcinolone—ulcerative colitis	4.07e-05	0.000553	CcSEcCtD
Levonorgestrel—Vertigo—Dexamethasone—ulcerative colitis	4.07e-05	0.000552	CcSEcCtD
Levonorgestrel—Vertigo—Betamethasone—ulcerative colitis	4.07e-05	0.000552	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—CALM3—ulcerative colitis	4.07e-05	0.00252	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—JAK2—ulcerative colitis	4.06e-05	0.00252	CbGpPWpGaD
Levonorgestrel—Syncope—Betamethasone—ulcerative colitis	4.06e-05	0.000551	CcSEcCtD
Levonorgestrel—Syncope—Dexamethasone—ulcerative colitis	4.06e-05	0.000551	CcSEcCtD
Levonorgestrel—Arrhythmia—Prednisone—ulcerative colitis	4.04e-05	0.00055	CcSEcCtD
Levonorgestrel—Infection—Triamcinolone—ulcerative colitis	4.04e-05	0.000549	CcSEcCtD
Levonorgestrel—Infection—Methylprednisolone—ulcerative colitis	4.03e-05	0.000548	CcSEcCtD
Levonorgestrel—Dizziness—Mesalazine—ulcerative colitis	4.02e-05	0.000546	CcSEcCtD
Levonorgestrel—Shock—Triamcinolone—ulcerative colitis	4e-05	0.000544	CcSEcCtD
Levonorgestrel—Insomnia—Prednisolone—ulcerative colitis	4e-05	0.000544	CcSEcCtD
Levonorgestrel—Alopecia—Prednisone—ulcerative colitis	4e-05	0.000544	CcSEcCtD
Levonorgestrel—Shock—Methylprednisolone—ulcerative colitis	4e-05	0.000543	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.98e-05	0.000541	CcSEcCtD
Levonorgestrel—Loss of consciousness—Dexamethasone—ulcerative colitis	3.98e-05	0.00054	CcSEcCtD
Levonorgestrel—Loss of consciousness—Betamethasone—ulcerative colitis	3.98e-05	0.00054	CcSEcCtD
Levonorgestrel—Mental disorder—Prednisone—ulcerative colitis	3.97e-05	0.000539	CcSEcCtD
Levonorgestrel—Nausea—Azathioprine—ulcerative colitis	3.96e-05	0.000539	CcSEcCtD
Levonorgestrel—Skin disorder—Methylprednisolone—ulcerative colitis	3.94e-05	0.000536	CcSEcCtD
Levonorgestrel—Erythema—Prednisone—ulcerative colitis	3.94e-05	0.000536	CcSEcCtD
Levonorgestrel—Malnutrition—Prednisone—ulcerative colitis	3.94e-05	0.000536	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.94e-05	0.000535	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.93e-05	0.000535	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—RELA—ulcerative colitis	3.93e-05	0.00244	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—JAK2—ulcerative colitis	3.93e-05	0.00244	CbGpPWpGaD
Levonorgestrel—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.93e-05	0.000533	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—CXCL8—ulcerative colitis	3.92e-05	0.00243	CbGpPWpGaD
Levonorgestrel—Insomnia—Hydrocortisone—ulcerative colitis	3.91e-05	0.000531	CcSEcCtD
Levonorgestrel—Hypertension—Betamethasone—ulcerative colitis	3.91e-05	0.000531	CcSEcCtD
Levonorgestrel—Hypertension—Dexamethasone—ulcerative colitis	3.91e-05	0.000531	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.89e-05	0.00241	CbGpPWpGaD
Levonorgestrel—Vomiting—Mesalazine—ulcerative colitis	3.86e-05	0.000525	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—NR5A2—ulcerative colitis	3.86e-05	0.00239	CbGpPWpGaD
Levonorgestrel—Myalgia—Betamethasone—ulcerative colitis	3.85e-05	0.000524	CcSEcCtD
Levonorgestrel—Myalgia—Dexamethasone—ulcerative colitis	3.85e-05	0.000524	CcSEcCtD
Levonorgestrel—Anxiety—Dexamethasone—ulcerative colitis	3.84e-05	0.000522	CcSEcCtD
Levonorgestrel—Anxiety—Betamethasone—ulcerative colitis	3.84e-05	0.000522	CcSEcCtD
Levonorgestrel—Rash—Mesalazine—ulcerative colitis	3.83e-05	0.000521	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—IL2—ulcerative colitis	3.83e-05	0.00237	CbGpPWpGaD
Levonorgestrel—Dermatitis—Mesalazine—ulcerative colitis	3.83e-05	0.00052	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.81e-05	0.00236	CbGpPWpGaD
Levonorgestrel—Headache—Mesalazine—ulcerative colitis	3.81e-05	0.000517	CcSEcCtD
Levonorgestrel—Discomfort—Betamethasone—ulcerative colitis	3.81e-05	0.000517	CcSEcCtD
Levonorgestrel—Discomfort—Dexamethasone—ulcerative colitis	3.81e-05	0.000517	CcSEcCtD
Levonorgestrel—Dyspepsia—Hydrocortisone—ulcerative colitis	3.8e-05	0.000517	CcSEcCtD
Levonorgestrel—Pain—Prednisolone—ulcerative colitis	3.78e-05	0.000514	CcSEcCtD
Levonorgestrel—Decreased appetite—Hydrocortisone—ulcerative colitis	3.76e-05	0.000511	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL2—ulcerative colitis	3.74e-05	0.00232	CbGpPWpGaD
Levonorgestrel—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.73e-05	0.000507	CcSEcCtD
Levonorgestrel—Fatigue—Hydrocortisone—ulcerative colitis	3.73e-05	0.000506	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.71e-05	0.000504	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3.7e-05	0.000503	CcSEcCtD
Levonorgestrel—Pain—Hydrocortisone—ulcerative colitis	3.7e-05	0.000502	CcSEcCtD
Levonorgestrel—Oedema—Dexamethasone—ulcerative colitis	3.69e-05	0.000502	CcSEcCtD
Levonorgestrel—Oedema—Betamethasone—ulcerative colitis	3.69e-05	0.000502	CcSEcCtD
Levonorgestrel—Insomnia—Triamcinolone—ulcerative colitis	3.68e-05	0.0005	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	3.68e-05	0.00228	CbGpPWpGaD
Levonorgestrel—Insomnia—Methylprednisolone—ulcerative colitis	3.67e-05	0.000499	CcSEcCtD
Levonorgestrel—Infection—Betamethasone—ulcerative colitis	3.67e-05	0.000499	CcSEcCtD
Levonorgestrel—Infection—Dexamethasone—ulcerative colitis	3.67e-05	0.000499	CcSEcCtD
Levonorgestrel—Anaemia—Prednisone—ulcerative colitis	3.64e-05	0.000495	CcSEcCtD
Levonorgestrel—Shock—Betamethasone—ulcerative colitis	3.63e-05	0.000494	CcSEcCtD
Levonorgestrel—Shock—Dexamethasone—ulcerative colitis	3.63e-05	0.000494	CcSEcCtD
Levonorgestrel—Dyspnoea—Triamcinolone—ulcerative colitis	3.63e-05	0.000493	CcSEcCtD
Levonorgestrel—Nervous system disorder—Dexamethasone—ulcerative colitis	3.62e-05	0.000492	CcSEcCtD
Levonorgestrel—Nervous system disorder—Betamethasone—ulcerative colitis	3.62e-05	0.000492	CcSEcCtD
Levonorgestrel—Nausea—Mesalazine—ulcerative colitis	3.61e-05	0.000491	CcSEcCtD
Levonorgestrel—Angioedema—Prednisone—ulcerative colitis	3.6e-05	0.000489	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—NFKB1—ulcerative colitis	3.59e-05	0.00222	CbGpPWpGaD
Levonorgestrel—Dyspepsia—Triamcinolone—ulcerative colitis	3.58e-05	0.000487	CcSEcCtD
Levonorgestrel—Dyspepsia—Methylprednisolone—ulcerative colitis	3.57e-05	0.000486	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Betamethasone—ulcerative colitis	3.57e-05	0.000485	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.57e-05	0.000485	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—IL1B—ulcerative colitis	3.56e-05	0.0022	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—ulcerative colitis	3.55e-05	0.0022	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP9—ulcerative colitis	3.54e-05	0.0022	CbGpPWpGaD
Levonorgestrel—Vertigo—Prednisone—ulcerative colitis	3.54e-05	0.000481	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.53e-05	0.00048	CcSEcCtD
Levonorgestrel—Syncope—Prednisone—ulcerative colitis	3.53e-05	0.00048	CcSEcCtD
Levonorgestrel—Anorexia—Dexamethasone—ulcerative colitis	3.52e-05	0.000478	CcSEcCtD
Levonorgestrel—Anorexia—Betamethasone—ulcerative colitis	3.52e-05	0.000478	CcSEcCtD
Levonorgestrel—Urticaria—Prednisolone—ulcerative colitis	3.52e-05	0.000478	CcSEcCtD
Levonorgestrel—Fatigue—Triamcinolone—ulcerative colitis	3.51e-05	0.000477	CcSEcCtD
Levonorgestrel—Fatigue—Methylprednisolone—ulcerative colitis	3.5e-05	0.000476	CcSEcCtD
Levonorgestrel—Pain—Triamcinolone—ulcerative colitis	3.48e-05	0.000473	CcSEcCtD
Levonorgestrel—Loss of consciousness—Prednisone—ulcerative colitis	3.46e-05	0.000471	CcSEcCtD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	3.44e-05	0.00213	CbGpPWpGaD
Levonorgestrel—Urticaria—Hydrocortisone—ulcerative colitis	3.43e-05	0.000467	CcSEcCtD
Levonorgestrel—Body temperature increased—Hydrocortisone—ulcerative colitis	3.42e-05	0.000464	CcSEcCtD
Levonorgestrel—Abdominal pain—Hydrocortisone—ulcerative colitis	3.42e-05	0.000464	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—HNF4A—ulcerative colitis	3.42e-05	0.00212	CbGpPWpGaD
Levonorgestrel—Hypertension—Prednisone—ulcerative colitis	3.4e-05	0.000462	CcSEcCtD
Levonorgestrel—Progesterone—ABCB1—ulcerative colitis	3.38e-05	0.0628	CrCbGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—STAT3—ulcerative colitis	3.37e-05	0.00209	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.36e-05	0.000457	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.36e-05	0.000457	CcSEcCtD
Levonorgestrel—Myalgia—Prednisone—ulcerative colitis	3.35e-05	0.000456	CcSEcCtD
Levonorgestrel—Testosterone—ALB—ulcerative colitis	3.34e-05	0.0622	CrCbGaD
Levonorgestrel—Anxiety—Prednisone—ulcerative colitis	3.34e-05	0.000454	CcSEcCtD
Levonorgestrel—Insomnia—Dexamethasone—ulcerative colitis	3.34e-05	0.000454	CcSEcCtD
Levonorgestrel—Insomnia—Betamethasone—ulcerative colitis	3.34e-05	0.000454	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.33e-05	0.000453	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—MAML2—ulcerative colitis	3.33e-05	0.00206	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.32e-05	0.000451	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—NFKB1—ulcerative colitis	3.32e-05	0.00206	CbGpPWpGaD
Levonorgestrel—Discomfort—Prednisone—ulcerative colitis	3.31e-05	0.00045	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	3.31e-05	0.00205	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	3.29e-05	0.00204	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Prednisolone—ulcerative colitis	3.26e-05	0.000443	CcSEcCtD
Levonorgestrel—Dyspepsia—Dexamethasone—ulcerative colitis	3.25e-05	0.000442	CcSEcCtD
Levonorgestrel—Dyspepsia—Betamethasone—ulcerative colitis	3.25e-05	0.000442	CcSEcCtD
Levonorgestrel—Urticaria—Triamcinolone—ulcerative colitis	3.23e-05	0.000439	CcSEcCtD
Levonorgestrel—Urticaria—Methylprednisolone—ulcerative colitis	3.23e-05	0.000438	CcSEcCtD
Levonorgestrel—Body temperature increased—Triamcinolone—ulcerative colitis	3.22e-05	0.000437	CcSEcCtD
Levonorgestrel—Oedema—Prednisone—ulcerative colitis	3.22e-05	0.000437	CcSEcCtD
Levonorgestrel—Abdominal pain—Methylprednisolone—ulcerative colitis	3.21e-05	0.000436	CcSEcCtD
Levonorgestrel—Decreased appetite—Dexamethasone—ulcerative colitis	3.21e-05	0.000436	CcSEcCtD
Levonorgestrel—Decreased appetite—Betamethasone—ulcerative colitis	3.21e-05	0.000436	CcSEcCtD
Levonorgestrel—Infection—Prednisone—ulcerative colitis	3.2e-05	0.000434	CcSEcCtD
Levonorgestrel—Testosterone—ABCB1—ulcerative colitis	3.19e-05	0.0594	CrCbGaD
Levonorgestrel—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.19e-05	0.000433	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.19e-05	0.000433	CcSEcCtD
Levonorgestrel—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.18e-05	0.000433	CcSEcCtD
Levonorgestrel—Fatigue—Betamethasone—ulcerative colitis	3.18e-05	0.000433	CcSEcCtD
Levonorgestrel—Fatigue—Dexamethasone—ulcerative colitis	3.18e-05	0.000433	CcSEcCtD
Levonorgestrel—Shock—Prednisone—ulcerative colitis	3.16e-05	0.00043	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—ABCB1—ulcerative colitis	3.16e-05	0.00196	CbGpPWpGaD
Levonorgestrel—Pain—Dexamethasone—ulcerative colitis	3.16e-05	0.000429	CcSEcCtD
Levonorgestrel—Pain—Betamethasone—ulcerative colitis	3.16e-05	0.000429	CcSEcCtD
Levonorgestrel—Nervous system disorder—Prednisone—ulcerative colitis	3.15e-05	0.000429	CcSEcCtD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.15e-05	0.00195	CbGpPWpGaD
Levonorgestrel—Skin disorder—Prednisone—ulcerative colitis	3.12e-05	0.000425	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisone—ulcerative colitis	3.11e-05	0.000423	CcSEcCtD
Levonorgestrel—Asthenia—Hydrocortisone—ulcerative colitis	3.1e-05	0.000421	CcSEcCtD
Levonorgestrel—Anorexia—Prednisone—ulcerative colitis	3.07e-05	0.000417	CcSEcCtD
Levonorgestrel—Pruritus—Hydrocortisone—ulcerative colitis	3.06e-05	0.000416	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.02e-05	0.00041	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.02e-05	0.00041	CcSEcCtD
Levonorgestrel—Hypersensitivity—Triamcinolone—ulcerative colitis	3e-05	0.000407	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.99e-05	0.000407	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—TGFB1—ulcerative colitis	2.99e-05	0.00185	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.98e-05	0.00185	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—STAT3—ulcerative colitis	2.98e-05	0.00185	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Hydrocortisone—ulcerative colitis	2.96e-05	0.000402	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	2.96e-05	0.00183	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—ADCY5—ulcerative colitis	2.95e-05	0.00183	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR5A2—ulcerative colitis	2.94e-05	0.00182	CbGpPWpGaD
Levonorgestrel—Urticaria—Betamethasone—ulcerative colitis	2.93e-05	0.000399	CcSEcCtD
Levonorgestrel—Urticaria—Dexamethasone—ulcerative colitis	2.93e-05	0.000399	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.93e-05	0.000398	CcSEcCtD
Levonorgestrel—Dizziness—Prednisolone—ulcerative colitis	2.93e-05	0.000398	CcSEcCtD
Levonorgestrel—Asthenia—Triamcinolone—ulcerative colitis	2.92e-05	0.000397	CcSEcCtD
Levonorgestrel—Body temperature increased—Betamethasone—ulcerative colitis	2.92e-05	0.000397	CcSEcCtD
Levonorgestrel—Body temperature increased—Dexamethasone—ulcerative colitis	2.92e-05	0.000397	CcSEcCtD
Levonorgestrel—Abdominal pain—Betamethasone—ulcerative colitis	2.92e-05	0.000397	CcSEcCtD
Levonorgestrel—Abdominal pain—Dexamethasone—ulcerative colitis	2.92e-05	0.000397	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—TGFB1—ulcerative colitis	2.92e-05	0.00181	CbGpPWpGaD
Levonorgestrel—Asthenia—Methylprednisolone—ulcerative colitis	2.91e-05	0.000396	CcSEcCtD
Levonorgestrel—Insomnia—Prednisone—ulcerative colitis	2.91e-05	0.000395	CcSEcCtD
Levonorgestrel—Pruritus—Triamcinolone—ulcerative colitis	2.88e-05	0.000391	CcSEcCtD
Levonorgestrel—Pruritus—Methylprednisolone—ulcerative colitis	2.87e-05	0.00039	CcSEcCtD
Levonorgestrel—Dizziness—Hydrocortisone—ulcerative colitis	2.86e-05	0.000388	CcSEcCtD
Levonorgestrel—Dyspepsia—Prednisone—ulcerative colitis	2.83e-05	0.000385	CcSEcCtD
Levonorgestrel—Decreased appetite—Prednisone—ulcerative colitis	2.8e-05	0.00038	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—VDR—ulcerative colitis	2.79e-05	0.00173	CbGpPWpGaD
Levonorgestrel—Rash—Prednisolone—ulcerative colitis	2.79e-05	0.000379	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisolone—ulcerative colitis	2.79e-05	0.000379	CcSEcCtD
Levonorgestrel—Diarrhoea—Methylprednisolone—ulcerative colitis	2.78e-05	0.000378	CcSEcCtD
Levonorgestrel—Fatigue—Prednisone—ulcerative colitis	2.77e-05	0.000377	CcSEcCtD
Levonorgestrel—Headache—Prednisolone—ulcerative colitis	2.77e-05	0.000377	CcSEcCtD
Levonorgestrel—Constipation—Prednisone—ulcerative colitis	2.75e-05	0.000374	CcSEcCtD
Levonorgestrel—Vomiting—Hydrocortisone—ulcerative colitis	2.75e-05	0.000373	CcSEcCtD
Levonorgestrel—Rash—Hydrocortisone—ulcerative colitis	2.73e-05	0.00037	CcSEcCtD
Levonorgestrel—Dermatitis—Hydrocortisone—ulcerative colitis	2.72e-05	0.00037	CcSEcCtD
Levonorgestrel—Headache—Hydrocortisone—ulcerative colitis	2.71e-05	0.000368	CcSEcCtD
Levonorgestrel—Dizziness—Triamcinolone—ulcerative colitis	2.69e-05	0.000366	CcSEcCtD
Levonorgestrel—Dizziness—Methylprednisolone—ulcerative colitis	2.69e-05	0.000365	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	2.68e-05	0.00166	CbGpPWpGaD
Levonorgestrel—Asthenia—Betamethasone—ulcerative colitis	2.65e-05	0.00036	CcSEcCtD
Levonorgestrel—Asthenia—Dexamethasone—ulcerative colitis	2.65e-05	0.00036	CcSEcCtD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	2.65e-05	0.00164	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—HNF4A—ulcerative colitis	2.63e-05	0.00163	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Prednisone—ulcerative colitis	2.63e-05	0.000357	CcSEcCtD
Levonorgestrel—Nausea—Prednisolone—ulcerative colitis	2.63e-05	0.000357	CcSEcCtD
Levonorgestrel—Pruritus—Betamethasone—ulcerative colitis	2.61e-05	0.000355	CcSEcCtD
Levonorgestrel—Pruritus—Dexamethasone—ulcerative colitis	2.61e-05	0.000355	CcSEcCtD
Levonorgestrel—Vomiting—Triamcinolone—ulcerative colitis	2.59e-05	0.000352	CcSEcCtD
Levonorgestrel—Vomiting—Methylprednisolone—ulcerative colitis	2.58e-05	0.000351	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	2.57e-05	0.00159	CbGpPWpGaD
Levonorgestrel—Nausea—Hydrocortisone—ulcerative colitis	2.57e-05	0.000349	CcSEcCtD
Levonorgestrel—Rash—Triamcinolone—ulcerative colitis	2.57e-05	0.000349	CcSEcCtD
Levonorgestrel—Dermatitis—Triamcinolone—ulcerative colitis	2.56e-05	0.000348	CcSEcCtD
Levonorgestrel—ESR1—Generic Transcription Pathway—MAML2—ulcerative colitis	2.56e-05	0.00159	CbGpPWpGaD
Levonorgestrel—Rash—Methylprednisolone—ulcerative colitis	2.56e-05	0.000348	CcSEcCtD
Levonorgestrel—Dermatitis—Methylprednisolone—ulcerative colitis	2.56e-05	0.000348	CcSEcCtD
Levonorgestrel—Urticaria—Prednisone—ulcerative colitis	2.55e-05	0.000347	CcSEcCtD
Levonorgestrel—Headache—Triamcinolone—ulcerative colitis	2.55e-05	0.000346	CcSEcCtD
Levonorgestrel—Headache—Methylprednisolone—ulcerative colitis	2.54e-05	0.000346	CcSEcCtD
Levonorgestrel—Abdominal pain—Prednisone—ulcerative colitis	2.54e-05	0.000345	CcSEcCtD
Levonorgestrel—Body temperature increased—Prednisone—ulcerative colitis	2.54e-05	0.000345	CcSEcCtD
Levonorgestrel—Diarrhoea—Dexamethasone—ulcerative colitis	2.53e-05	0.000343	CcSEcCtD
Levonorgestrel—Diarrhoea—Betamethasone—ulcerative colitis	2.53e-05	0.000343	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IL6—ulcerative colitis	2.52e-05	0.00156	CbGpPWpGaD
Levonorgestrel—PGR—epithelium—ulcerative colitis	2.51e-05	0.0794	CbGeAlD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	2.46e-05	0.00152	CbGpPWpGaD
Levonorgestrel—Dizziness—Betamethasone—ulcerative colitis	2.44e-05	0.000332	CcSEcCtD
Levonorgestrel—Dizziness—Dexamethasone—ulcerative colitis	2.44e-05	0.000332	CcSEcCtD
Levonorgestrel—PGR—smooth muscle tissue—ulcerative colitis	2.42e-05	0.0765	CbGeAlD
Levonorgestrel—Nausea—Triamcinolone—ulcerative colitis	2.42e-05	0.000329	CcSEcCtD
Levonorgestrel—Nausea—Methylprednisolone—ulcerative colitis	2.41e-05	0.000328	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—ulcerative colitis	2.4e-05	0.00149	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	2.4e-05	0.00149	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SEL1L—ulcerative colitis	2.38e-05	0.00148	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Prednisone—ulcerative colitis	2.37e-05	0.000322	CcSEcCtD
Levonorgestrel—CYP19A1—Metabolism—CHP1—ulcerative colitis	2.35e-05	0.00146	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.35e-05	0.00146	CbGpPWpGaD
Levonorgestrel—Vomiting—Dexamethasone—ulcerative colitis	2.35e-05	0.000319	CcSEcCtD
Levonorgestrel—Vomiting—Betamethasone—ulcerative colitis	2.35e-05	0.000319	CcSEcCtD
Levonorgestrel—Rash—Dexamethasone—ulcerative colitis	2.33e-05	0.000316	CcSEcCtD
Levonorgestrel—Rash—Betamethasone—ulcerative colitis	2.33e-05	0.000316	CcSEcCtD
Levonorgestrel—Dermatitis—Dexamethasone—ulcerative colitis	2.33e-05	0.000316	CcSEcCtD
Levonorgestrel—Dermatitis—Betamethasone—ulcerative colitis	2.33e-05	0.000316	CcSEcCtD
Levonorgestrel—Headache—Dexamethasone—ulcerative colitis	2.31e-05	0.000314	CcSEcCtD
Levonorgestrel—Headache—Betamethasone—ulcerative colitis	2.31e-05	0.000314	CcSEcCtD
Levonorgestrel—Asthenia—Prednisone—ulcerative colitis	2.31e-05	0.000314	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—JAK2—ulcerative colitis	2.31e-05	0.00143	CbGpPWpGaD
Levonorgestrel—Pruritus—Prednisone—ulcerative colitis	2.28e-05	0.000309	CcSEcCtD
Levonorgestrel—ESR1—Gene Expression—NR5A2—ulcerative colitis	2.27e-05	0.00141	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.2e-05	0.00136	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Prednisone—ulcerative colitis	2.2e-05	0.000299	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL6—ulcerative colitis	2.2e-05	0.00136	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PPARG—ulcerative colitis	2.2e-05	0.00136	CbGpPWpGaD
Levonorgestrel—Nausea—Betamethasone—ulcerative colitis	2.19e-05	0.000298	CcSEcCtD
Levonorgestrel—Nausea—Dexamethasone—ulcerative colitis	2.19e-05	0.000298	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—HNF4A—ulcerative colitis	2.16e-05	0.00134	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—VDR—ulcerative colitis	2.13e-05	0.00132	CbGpPWpGaD
Levonorgestrel—Dizziness—Prednisone—ulcerative colitis	2.13e-05	0.000289	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	2.12e-05	0.00131	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAML2—ulcerative colitis	2.1e-05	0.0013	CbGpPWpGaD
Levonorgestrel—Vomiting—Prednisone—ulcerative colitis	2.04e-05	0.000278	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.04e-05	0.00126	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—DLD—ulcerative colitis	2.03e-05	0.00126	CbGpPWpGaD
Levonorgestrel—Rash—Prednisone—ulcerative colitis	2.03e-05	0.000276	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisone—ulcerative colitis	2.03e-05	0.000275	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—IL6—ulcerative colitis	2.02e-05	0.00125	CbGpPWpGaD
Levonorgestrel—Headache—Prednisone—ulcerative colitis	2.01e-05	0.000274	CcSEcCtD
Levonorgestrel—AR—epithelium—ulcerative colitis	2e-05	0.0633	CbGeAlD
Levonorgestrel—SRD5A1—Metabolism—ALB—ulcerative colitis	1.98e-05	0.00123	CbGpPWpGaD
Levonorgestrel—ESR1—epithelium—ulcerative colitis	1.96e-05	0.0621	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—CXCR1—ulcerative colitis	1.96e-05	0.00122	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—PPARG—ulcerative colitis	1.95e-05	0.00121	CbGpPWpGaD
Levonorgestrel—PGR—lymphoid tissue—ulcerative colitis	1.93e-05	0.0612	CbGeAlD
Levonorgestrel—AR—smooth muscle tissue—ulcerative colitis	1.93e-05	0.061	CbGeAlD
Levonorgestrel—Nausea—Prednisone—ulcerative colitis	1.91e-05	0.00026	CcSEcCtD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	1.89e-05	0.00117	CbGpPWpGaD
Levonorgestrel—ESR1—smooth muscle tissue—ulcerative colitis	1.89e-05	0.0598	CbGeAlD
Levonorgestrel—AR—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.86e-05	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.81e-05	0.00112	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—ulcerative colitis	1.73e-05	0.00107	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL20—ulcerative colitis	1.72e-05	0.00107	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.7e-05	0.00105	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	1.69e-05	0.00105	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.67e-05	0.00104	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HNF4A—ulcerative colitis	1.64e-05	0.00102	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—VDR—ulcerative colitis	1.64e-05	0.00102	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNA12—ulcerative colitis	1.62e-05	0.001	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAML2—ulcerative colitis	1.6e-05	0.000993	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.59e-05	0.000983	CbGpPWpGaD
Levonorgestrel—SHBG—liver—ulcerative colitis	1.58e-05	0.05	CbGeAlD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.57e-05	0.000973	CbGpPWpGaD
Levonorgestrel—AR—lymphoid tissue—ulcerative colitis	1.54e-05	0.0487	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—CXCR2—ulcerative colitis	1.53e-05	0.000951	CbGpPWpGaD
Levonorgestrel—AR—digestive system—ulcerative colitis	1.52e-05	0.0481	CbGeAlD
Levonorgestrel—ESR1—lymphoid tissue—ulcerative colitis	1.51e-05	0.0478	CbGeAlD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.5e-05	0.000932	CbGpPWpGaD
Levonorgestrel—ESR1—digestive system—ulcerative colitis	1.49e-05	0.0472	CbGeAlD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—ulcerative colitis	1.48e-05	0.000919	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	1.45e-05	0.0009	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR6—ulcerative colitis	1.44e-05	0.000894	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.4e-05	0.000866	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SEL1L—ulcerative colitis	1.4e-05	0.000866	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAML2—ulcerative colitis	1.37e-05	0.000848	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—VDR—ulcerative colitis	1.34e-05	0.000833	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.31e-05	0.000811	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	1.3e-05	0.000805	CbGpPWpGaD
Levonorgestrel—CYP19A1—liver—ulcerative colitis	1.28e-05	0.0405	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—PTGER4—ulcerative colitis	1.27e-05	0.000787	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HNF4A—ulcerative colitis	1.27e-05	0.000785	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAML2—ulcerative colitis	1.23e-05	0.000765	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.22e-05	0.000757	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—ulcerative colitis	1.18e-05	0.000733	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GHRL—ulcerative colitis	1.16e-05	0.000721	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCR1—ulcerative colitis	1.15e-05	0.000713	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—ulcerative colitis	1.14e-05	0.000708	CbGpPWpGaD
Levonorgestrel—AR—liver—ulcerative colitis	1.13e-05	0.0359	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—CALM3—ulcerative colitis	1.13e-05	0.000698	CbGpPWpGaD
Levonorgestrel—ESR1—liver—ulcerative colitis	1.11e-05	0.0352	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—RIPK2—ulcerative colitis	1.11e-05	0.000688	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.08e-05	0.000667	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.07e-05	0.000665	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—VDR—ulcerative colitis	1.02e-05	0.000635	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL20—ulcerative colitis	1.01e-05	0.000626	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS1—ulcerative colitis	9.81e-06	0.000608	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.64e-06	0.000598	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB2—ulcerative colitis	9.62e-06	0.000597	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNA12—ulcerative colitis	9.5e-06	0.000589	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—ulcerative colitis	9.37e-06	0.000581	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCR2—ulcerative colitis	9e-06	0.000558	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CALM3—ulcerative colitis	8.83e-06	0.000547	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR6—ulcerative colitis	8.47e-06	0.000525	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.44e-06	0.000523	CbGpPWpGaD
Levonorgestrel—CYP3A4—digestive system—ulcerative colitis	8.33e-06	0.0264	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—ADCY5—ulcerative colitis	8.17e-06	0.000506	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAML2—ulcerative colitis	8.03e-06	0.000497	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—VDR—ulcerative colitis	7.89e-06	0.000489	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTGER4—ulcerative colitis	7.45e-06	0.000462	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—ulcerative colitis	7.14e-06	0.000443	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCB1—ulcerative colitis	6.87e-06	0.000426	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CHP1—ulcerative colitis	6.86e-06	0.000425	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GHRL—ulcerative colitis	6.82e-06	0.000423	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CALM3—ulcerative colitis	6.61e-06	0.00041	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RIPK2—ulcerative colitis	6.51e-06	0.000404	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADCY5—ulcerative colitis	6.4e-06	0.000397	CbGpPWpGaD
Levonorgestrel—CYP3A4—liver—ulcerative colitis	6.21e-06	0.0196	CbGeAlD
Levonorgestrel—CYP3A4—Metabolism—DLD—ulcerative colitis	5.92e-06	0.000367	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB2—ulcerative colitis	5.65e-06	0.00035	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—ulcerative colitis	5.5e-06	0.000341	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JAK2—ulcerative colitis	5.09e-06	0.000316	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RELA—ulcerative colitis	4.93e-06	0.000306	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADCY5—ulcerative colitis	4.79e-06	0.000297	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—ulcerative colitis	4.78e-06	0.000296	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—ulcerative colitis	4.65e-06	0.000288	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—ulcerative colitis	4.44e-06	0.000275	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—ulcerative colitis	4.29e-06	0.000266	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—ulcerative colitis	4.2e-06	0.000261	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NFKB1—ulcerative colitis	4.16e-06	0.000258	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—ulcerative colitis	3.76e-06	0.000233	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—ulcerative colitis	3.74e-06	0.000232	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—ulcerative colitis	3.46e-06	0.000215	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JAK2—ulcerative colitis	2.99e-06	0.000185	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RELA—ulcerative colitis	2.89e-06	0.000179	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.86e-06	0.000177	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—ulcerative colitis	2.85e-06	0.000177	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—ulcerative colitis	2.73e-06	0.000169	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—ulcerative colitis	2.61e-06	0.000162	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—ulcerative colitis	2.61e-06	0.000162	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.58e-06	0.00016	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—ulcerative colitis	2.47e-06	0.000153	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NFKB1—ulcerative colitis	2.44e-06	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—ulcerative colitis	2.19e-06	0.000136	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—ulcerative colitis	2.03e-06	0.000126	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2e-06	0.000124	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.87e-06	0.000116	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—ulcerative colitis	1.67e-06	0.000104	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—ulcerative colitis	1.53e-06	9.5e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.39e-06	8.64e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—ulcerative colitis	1.25e-06	7.77e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.1e-06	6.8e-05	CbGpPWpGaD
